Abstract
BackgroundNRG1 gene fusions may be clinically actionable, since cancers carrying the fusion transcripts can be sensitive to tyrosine kinase inhibitors......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
